Organization
St. Petersburg Research Institute of Vaccines and Sera
4 clinical trials
Clinical trial
A Double-blind, Randomized, Prospective, Placebo-controlled Trial to Assess the Immunogenicity, Safety, and Tolerability of a Coronavirus Vaccine in Healthy Volunteers Aged 18 to 60 YearsStatus: Completed, Estimated PCD: 2021-08-30
Clinical trial
Multicentre, Double-blind, Randomized, Prospective, Placebo-controlled Trial to Assess the Immunogenicity, Efficacy and Safety of the Coronavirus Vaccine in Healthy Volunteers Aged 18 Years and OlderStatus: Active (not recruiting), Estimated PCD: 2023-10-30
Clinical trial
Randomized, Double-blind, Comparative, Controlled Trial of Tolerability, Safety and Immunogenicity of the Flu-M Tetra Vaccine in Children Between 6 Months and 17 Years OldStatus: Recruiting, Estimated PCD: 2023-06-30
Clinical trial
Double-blind Comparative Randomized Tolerability, Safety and Immunogenicity Trial of the Flu-M Quadro Tetravalent Inactivated Split Influenza Vaccine, Solution for Intramuscular Injection, FSUE SPbSRIVS FMBA of Russia, in Volunteers Aged 18-60 YearsStatus: Completed, Estimated PCD: 2020-12-08